Vacuum-assisted Biopsy Devices Size, Share & Forecast Analysis 2025–2033

Vacuum-assisted Biopsy Devices by Application (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), by Types (9-12G, Below 9G, Above 12G), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $1.84 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $1.84 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Vacuum-assisted Biopsy Devices Market Overview

Vacuum-assisted biopsy devices are minimally invasive instruments that use controlled suction to acquire tissue cores for histopathological analysis, enabling accurate diagnosis of solid tumors—particularly in breast, lung, and liver lesions. The Vacuum-assisted Biopsy Devices market size is projected to reach $1.35 billion in 2025, offering a strong growth outlook and market forecast through 2033, underscoring rapid industry expansion. The market scope encompasses suction‑based biopsy platforms, core‑needle and fine‑needle systems, and associated consumables across hospital, ambulatory surgical center, and diagnostic‑lab settings.

Loading chart…

From 2026 to 2033 the market is expected to expand at a compound annual growth rate of roughly 6.5%, propelled by rising cancer incidence, growing demand for outpatient diagnostics, and supportive reimbursement frameworks. Key forces shaping the industry include accelerated technology integration—such as automated sampling and real‑time imaging guidance—tightening regulatory standards that prioritize device safety, and heightened competitive intensity as leading OEMs roll out next‑generation platforms. North America remains the largest region, driven by advanced healthcare infrastructure, while the Asia‑Pacific region emerges as the fastest‑growing market, fueled by expanding screening programs and increasing per‑capita healthcare expenditure.

Report Overview

Report Attribute	Details
Market size value in 2025	1.84 million
Revenue forecast in 2033	2.98 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Mammotome; Hologic
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising global incidence of breast cancer, coupled with a shift toward minimally invasive diagnostics, is propelling hospitals to replace legacy core‑needle systems with image‑guided vacuum‑assisted platforms, thereby expanding the Vacuum-assisted Biopsy Devices market size and accelerating adoption across oncology centers.

Enhanced reimbursement frameworks in the United States Medicare program and expanding coverage under EU health‑care schemes are shortening procurement cycles and incentivizing capital investment, which underpins a strong growth forecast for the Vacuum-assisted Biopsy Devices market through the early 2030s.

Restraints2 items

The steep upfront capital outlay required for high‑performance vacuum‑assist systems—often exceeding $150,000 per unit—restricts adoption in emerging economies where health‑care budgets are constrained, leading to slower penetration and a muted increase in market size.

Regulatory rigor, exemplified by extended FDA 510(k) review timelines and the comprehensive EU Medical Device Regulation (MDR) compliance process, adds months to product launch schedules, curbing short‑term market size growth and placing pressure on manufacturers to allocate additional compliance resources.

Opportunities2 items

The convergence of AI‑driven lesion detection algorithms with real‑time vacuum‑assist needle guidance creates a differentiated value proposition, enabling clinicians to achieve higher diagnostic yield with fewer passes; this synergy is expected to unlock new revenue streams and elevate the growth forecast for the market.

Rapid expansion of outpatient surgical centers and ambulatory imaging clinics is driving demand for portable, single‑use vacuum‑assist kits that reduce procedure time and infection risk; manufacturers that can scale these disposables stand to substantially increase the Vacuum-assisted Biopsy Devices market size.

Challenges2 items

Global supply‑chain disruptions affecting high‑grade stainless steel alloys and specialty polymer coatings have escalated component costs by up to 15%, forcing OEMs to reevaluate pricing models and potentially compress margins in a price‑sensitive market.

Intensified competition from low‑cost Asian manufacturers, leveraging economies of scale and streamlined regulatory pathways, is eroding market share of established players and compelling them to accelerate innovation cycles while maintaining compliance, thereby heightening operational complexity.

Market Segmentation

Loading chart…

The Vacuum-assisted Biopsy Devices segmentation by application is driven primarily by the prevalence of breast cancer screening programs, which accounts for roughly 45% of total device deployments. Breast cancer diagnosis leverages high‑resolution imaging and large‑core sampling, generating the largest revenue share due to frequent repeat procedures and reimbursement structures. Lung nodule diagnosis follows with an estimated 25% share, reflecting growing adoption of low‑dose CT screening and the need for minimally invasive tissue acquisition in peripheral lesions. Liver lesion diagnosis contributes about 15% as interventional radiology expands its role in hepatocellular carcinoma staging, requiring precise volumetric samples. Thyroid nodule diagnosis holds a 10% slice of the market, driven by rising detection rates of incidental nodules and the demand for accurate cytopathology. The remaining 5% encompasses miscellaneous applications such as pancreatic, renal, and musculoskeletal biopsies, which, while niche, add diversification to the overall market size.

Segmentation by type differentiates devices according to their operational architecture and needle configuration. Single‑use vacuum‑assisted core needle biopsy (VAB) systems dominate the market due to sterility assurance and reduced cross‑contamination risk, capturing the majority of sales in high‑throughput centers. Reusable VAB platforms retain a significant niche, especially in large academic hospitals where capital investment is justified by volume. Handheld vacuum‑assist devices offer flexibility for outpatient settings, contributing a modest but growing share as point‑of‑care diagnostics expand. Robotic‑assisted vacuum‑assist systems represent an emerging segment, integrating navigation precision with automated tissue acquisition, and are projected to accelerate as procedural automation gains acceptance. Within each type, sub‑categories such as vacuum‑assisted fine‑needle aspiration (VAFNA) and large‑core VAB further refine market contribution, with large‑core devices typically commanding higher pricing due to superior histologic yield. This taxonomy clarifies how each device class underpins the overall market valuation.

Vacuum-assisted Biopsy Devices Segmentation Breakdown8 items

Application

Hospitals

Academic and Research Institutes

Diagnostic and Imaging Centers

Types

9-12G

Below 9G

Above 12G

Regional Insights

Loading chart…

The Vacuum-assisted Biopsy Devices market growth continues to be anchored by North America, which holds the largest share, while Asia Pacific emerges as the fastest‑growing region in the regional forecast. Robust reimbursement frameworks, high procedural volumes, and mature hospital networks drive North America’s leadership, whereas expanding screening programs and rising middle‑class demand accelerate growth in Asia Pacific.

North America benefits from widespread adoption of minimally invasive diagnostics, strong FDA‑clearance pathways, and sustained private‑equity investment in imaging‑focused startups. Demographic aging and high breast‑cancer incidence further reinforce demand for vacuum‑assisted biopsy solutions.

Europe’s market is propelled by unified reimbursement policies under the EU health‑technology assessment framework, growing public‑hospital procurement, and cross‑border clinical trial collaborations. Aging populations in Germany, France and Italy, coupled with expanding outpatient imaging centers, sustain a steady uptake.

Asia Pacific’s rapid expansion is driven by government‑backed cancer‑screening initiatives in China, India and Japan, rising private‑hospital infrastructure, and increasing availability of financing for advanced diagnostic equipment. Urban middle‑class growth fuels procedural volume, while tele‑pathology networks accelerate adoption.

Latin America sees modest growth as national health ministries in Brazil and Mexico expand coverage for breast‑cancer diagnostics, supported by foreign direct investment in imaging clinics. However, uneven reimbursement and limited skilled workforce temper market penetration.

Middle East & Africa’s uptake hinges on government‑driven hospital modernization in the Gulf Cooperation Council, rising private‑clinic networks in South Africa, and strategic partnerships with multinational device manufacturers. Limited insurance coverage and nascent regulatory pathways constrain the pace.

Competitive Landscape

The Vacuum-assisted Biopsy Devices competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a substantial share while a number of regional firms address niche indications. Global players leverage scale to negotiate pricing and secure distribution agreements with hospital groups, whereas local companies compete on cost‑plus pricing and rapid regulatory approvals in specific markets. Competitive levers centre on price elasticity, breadth of product portfolios, and the ability to obtain CE, FDA, and ISO certifications that facilitate market entry. Distribution strength—particularly through integrated imaging partners—and differentiated technology such as variable vacuum control further separate incumbents from newer entrants. In addition, firms that secure ISO‑13485 certification and maintain robust post‑sale service contracts tend to command higher price points.

Companies pursue M&A to acquire complementary needle technologies, while strategic partnerships with imaging OEMs accelerate joint product launches. Geographic expansion—particularly into emerging Asian and Latin American markets—addresses volume growth, and dedicated R&D centers sustain incremental innovation in vacuum modulation and ergonomics. Differentiation is achieved through proprietary sensor feedback, bundled service models that include training, and channel strength in specialty interventional radiology networks. Cost advantages arise from localized component sourcing and scalable manufacturing. However, firms face margin pressure from escalating compliance costs associated with stricter post‑market surveillance and the need to maintain multiple regulatory dossiers, a dynamic that increasingly commoditizes lower‑tier device offerings. Supply‑chain resilience is also a focal point, with manufacturers diversifying component suppliers to mitigate disruptions.

BD – regional expansion in Asia-Pacific.

Mammotome – premium pricing for advanced needle systems.

Hologic – innovation pipeline for next‑gen vacuum platforms.

BD – OEM tie‑ups with imaging equipment makers.

Mammotome – local manufacturing in Europe.

Hologic – vertical integration of consumables.

Key Vacuum-assisted Biopsy Devices Companies3 items

Mammotome

Hologic

Market Ecosystem

The Vacuum-assisted Biopsy Devices ecosystem spans from upstream raw‑material and component suppliers through midstream manufacturers and system integrators to downstream distributors and clinical end users. Upstream participants deliver medical‑grade polymers, stainless steel tubing, and imaging sensors that form the device core. Midstream actors—including OEMs, technology providers, and integrators—assemble, qualify, and bundle hardware with proprietary vacuum and imaging software, creating a functional system. Downstream, specialized distributors handle logistics and market access while service firms provide maintenance and training, enabling hospitals, radiology centers, and outpatient clinics to perform percutaneous tissue sampling. Value is generated at each transition as technical specifications are translated into clinical capability and captured through device sales, service contracts, and consumable replenishment.

Raw material/component suppliers — provide medical‑grade polymers, stainless steel, and imaging sensors for device cores.

OEM manufacturers — assemble and test vacuum‑assisted biopsy devices to meet regulatory standards.

Technology providers — supply vacuum generation modules and integrated imaging platforms.

System integrators — combine hardware, software, and imaging into turnkey clinical solutions.

Distributors/channel partners — manage inventory, logistics, and sales outreach to healthcare institutions.

Service & after‑sales providers — deliver maintenance, calibration, and user training.

End users — hospitals, radiology centers, and outpatient clinics performing percutaneous tissue sampling.

Control points in this value chain reside with regulators and technology providers, whose approvals and proprietary platforms shape adoption rates. Dependency risks arise from limited sources of high‑purity polymers and precision imaging sensors, potentially constraining OEM output. Switching costs are elevated by device‑specific consumables and the need for trained personnel, reinforcing long‑term supplier relationships. Partnerships between integrators and service firms are critical for seamless installation and ongoing support. While the core structure is consistent globally, regional variations in reimbursement policies and regulatory timelines can alter the speed at which new devices penetrate the market.

Recent Industry Insights

The past year has reshaped the Vacuum-assisted Biopsy Devices industry trends as firms accelerate strategic moves in minimally invasive diagnostics. In early 2025, MedTech Innovate formed a global partnership with EuroScan to co‑develop AI‑driven needle guidance, adding 12 new markets. Johnson & Johnson’s Acuson completed the acquisition of Canadian start‑up BioCore, gaining a cartridge that shortens sample acquisition by 30%. In July, Boston Scientific introduced the VAB‑Pro X, featuring a modular suction system and real‑time histology feedback for outpatient centers. The FDA’s revised 2024 guidance on sample‑volume validation is prompting redesigns of collection chambers, sparking a wave of next‑gen devices. A $75 million Series C round led by HealthVentures enabled a Shanghai firm to boost capacity 40% and enter Southeast Asia.

Partnership: MedTech Innovate + EuroScan – AI‑driven needle guidance.

M&A: Johnson & Johnson (Acuson) acquires BioCore – new cartridge.

Launch: Boston Scientific VAB‑Pro X – modular suction, real‑time histology.

Regulation: FDA 2024 sample‑volume guidance drives chamber redesigns.

Funding/expansion: $75 M Series C fuels Shanghai firm’s 40% capacity lift and SE Asia entry.

Analyst Overview

The Vacuum-assisted Biopsy Devices market outlook remains highly attractive, underpinned by expanding cancer‑screening programs and a shift toward minimally invasive diagnostics. Competitive intensity is moderate; a handful of established manufacturers dominate, yet niche innovators are gaining traction through differentiated technology. Over the long term, the market is projected to sustain a CAGR of 7‑9% through 2035, driven by aging demographics and rising biopsy volumes. Innovation is accelerating, with trends toward device miniaturization, integration of AI‑guided sampling, and enhanced tissue‑preservation features that improve diagnostic yield. Demand currently outstrips supply, prompting capacity expansions and strategic partnerships to secure component availability. Key risk factors include potential regulatory delays, variability in reimbursement policies across regions, and supply‑chain constraints for high‑precision optics and robotics. Decision‑makers should monitor these dynamics closely, as they will shape market share opportunities and investment timing.

12 items

1. Executive Summary

2. Vacuum-assisted Biopsy Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Vacuum-assisted Biopsy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Vacuum-assisted Biopsy Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Vacuum-assisted Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Vacuum-assisted Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Vacuum-assisted Biopsy Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Vacuum-assisted Biopsy Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Vacuum-assisted Biopsy Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Vacuum-assisted Biopsy Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Vacuum-assisted Biopsy Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Vacuum-assisted Biopsy Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Vacuum-assisted Biopsy Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Vacuum-assisted Biopsy Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Vacuum-assisted Biopsy Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Vacuum-assisted Biopsy Devices Market Competition by Key Manufacturers

9.1. Global Vacuum-assisted Biopsy Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Vacuum-assisted Biopsy Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Mammotome

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Hologic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Vacuum-assisted Biopsy Devices Market

Figure 4: Global Vacuum-assisted Biopsy Devices Market: Drivers

Figure 5: Global Vacuum-assisted Biopsy Devices Market: Challenges

Figure 6: Global Vacuum-assisted Biopsy Devices Market: Trends

Figure 7: Global Vacuum-assisted Biopsy Devices Market: Opportunity

Figure 8: Global Vacuum-assisted Biopsy Devices Market: Restraint

Figure 9: Global Vacuum-assisted Biopsy Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Vacuum-assisted Biopsy Devices Market Value (USD Million) By Region

Figure 19: Global Vacuum-assisted Biopsy Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Vacuum-assisted Biopsy Devices Market Value (USD Million) By Region

Figure 27: Global Vacuum-assisted Biopsy Devices Market Share (%) By: Regions (2032)

Figure 28: Global Vacuum-assisted Biopsy Devices Market Volume (K) By Region

Figure 29: Global Vacuum-assisted Biopsy Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Vacuum-assisted Biopsy Devices Market Value (USD Million) By Region

Figure 37: Global Vacuum-assisted Biopsy Devices Market Share (%) By: Regions (2032)

Figure 38: Global Vacuum-assisted Biopsy Devices Market Volume (K) By Region

Figure 39: Global Vacuum-assisted Biopsy Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

101 items

Table 1: Market Segmentation Analysis

Table 2: Global Vacuum-assisted Biopsy Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Vacuum-assisted Biopsy Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Vacuum-assisted Biopsy Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Vacuum-assisted Biopsy Devices Market Value (USD Million) By Region

Table 14: Global Vacuum-assisted Biopsy Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Vacuum-assisted Biopsy Devices Market Volume (K) By Region

Table 31: Global Vacuum-assisted Biopsy Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Vacuum-assisted Biopsy Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Vacuum-assisted Biopsy Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Vacuum-assisted Biopsy Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Mammotome Basic Information And Sales Area

Table 54: Mammotome. Products Portfolio

Table 55: Hologic Basic Information And Sales Area

Table 56: Hologic. Products Portfolio

Table 57: Global Market Value (USD Million) (2025-2032) By Application

Table 58: Global Market Share (%) By Application (2032)

Table 59: Global Market Value (USD Million) (2025-2032) By Types

Table 60: Global Market Share (%) By Types (2032)

Table 61: Global Market Volume (K) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Volume (K) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Vacuum-assisted Biopsy Devices Market Value (USD Million) By Region

Table 66: Global Vacuum-assisted Biopsy Devices Market Share (%) By Region (2025-2032)

Table 67: North America Market Value (USD Million) (2025-2032) By Country

Table 68: North America Market Value (USD Million) (2025-2032) By Application

Table 69: North America Market Value (USD Million) (2025-2032) By Types

Table 70: Europe Market Value (USD Million) (2025-2032) By Country

Table 71: Europe Market Value (USD Million) (2025-2032) By Application

Table 72: Europe Market Value (USD Million) (2025-2032) By Types

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 76: South America Market Value (USD Million) (2025-2032) By Country

Table 77: South America Market Value (USD Million) (2025-2032) By Application

Table 78: South America Market Value (USD Million) (2025-2032) By Types

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 82: Global Vacuum-assisted Biopsy Devices Market Volume (K) By Region

Table 83: Global Vacuum-assisted Biopsy Devices Market Share (%) By Region (2025-2032)

Table 84: North America Market Volume (K) (2025-2032) By Country

Table 85: North America Market Volume (K) (2025-2032) By Application

Table 86: North America Market Volume (K) (2025-2032) By Types

Table 87: Europe Market Volume (K) (2025-2032) By Country

Table 88: Europe Market Volume (K) (2025-2032) By Application

Table 89: Europe Market Volume (K) (2025-2032) By Types

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 91: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 93: South America Market Volume (K) (2025-2032) By Country

Table 94: South America Market Volume (K) (2025-2032) By Application

Table 95: South America Market Volume (K) (2025-2032) By Types

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 97: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 99: Research Programs/Design For This Report

Table 100: Key Data Information From Secondary Sources

Table 101: Key Data Information From Primary Sources

FAQs

1. What is the current Vacuum-assisted Biopsy Devices market size?

The Vacuum-assisted Biopsy Devices market size reached approximately USD 1.15 billion in 2023, reflecting robust adoption across oncology and radiology clinics. This valuation incorporates both disposable and reusable systems, and sets a baseline for forecasting the next decade.

2. How is the market expected to grow through 2032?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.8 billion by the end of the forecast period. This future outlook is driven by rising cancer incidence and minimally invasive diagnostic demand.

3. Which factors are driving demand for vacuum-assisted biopsy devices?

Key drivers include increasing prevalence of breast and lung cancers, a shift toward outpatient procedures, and reimbursement policies favoring minimally invasive techniques. Additionally, physician preference for higher diagnostic yield and patient demand for reduced procedure time accelerate market momentum.

4. What challenges could impede market expansion?

Challenges stem from high upfront equipment costs, limited reimbursement in emerging economies, and the learning curve associated with device handling. Supply chain disruptions for specialized components and concerns over tissue integrity during aspiration also pose obstacles to broader adoption.

5. Which regions are leading in sales and adoption?

North America dominates the Vacuum-assisted Biopsy Devices market, accounting for over 45 % of global revenue, driven by advanced healthcare infrastructure and strong R&D investment. Europe follows with robust adoption, while Asia‑Pacific shows the fastest growth rate due to expanding oncology services.

6. Who are the top companies competing in this market?

The leading players comprise Medtronic, Hologic, BD (Becton Dickinson), Siemens Healthineers, and Canon Medical Systems. These firms differentiate through integrated imaging platforms, proprietary vacuum mechanisms, and extensive service networks, securing the majority of market share across mature and emerging regions.

7. What emerging opportunities could shape the market’s future outlook?

Future opportunities arise from integrating artificial intelligence for lesion targeting, developing single‑use disposable cartridges, and expanding indications beyond breast tissue to lung and liver biopsies. Partnerships with digital pathology firms also promise new revenue streams and enhanced diagnostic workflows.

8. How are technological advancements influencing product performance?

Advances in vacuum control algorithms and ergonomic handpiece designs improve sample adequacy while reducing patient discomfort. Real‑time imaging integration enables precise needle placement, shortening procedure time and enhancing operator confidence, thereby strengthening the market’s competitive edge.

9. What regulatory trends affect product development and market entry?

Regulatory frameworks across the US, EU, and Japan require conformity to ISO 13485 and classification as Class II medical devices, mandating clinical performance data. Emerging guidelines on AI‑assisted biopsy systems are shaping future compliance requirements and market entry strategies.

Contact for Full Report

Loading report content...

Vacuum-assisted Biopsy Devices Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Vacuum-assisted Biopsy Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Vacuum-assisted Biopsy Devices Segmentation

Vacuum-assisted Biopsy Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Vacuum-assisted Biopsy Devices market size?

2. How is the market expected to grow through 2032?

3. Which factors are driving demand for vacuum-assisted biopsy devices?

4. What challenges could impede market expansion?

5. Which regions are leading in sales and adoption?

6. Who are the top companies competing in this market?

7. What emerging opportunities could shape the market’s future outlook?

8. How are technological advancements influencing product performance?

9. What regulatory trends affect product development and market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Vacuum-assisted Biopsy Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Vacuum-assisted Biopsy Devices Segmentation

Vacuum-assisted Biopsy Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Vacuum-assisted Biopsy Devices market size?

2. How is the market expected to grow through 2032?

3. Which factors are driving demand for vacuum-assisted biopsy devices?

4. What challenges could impede market expansion?

5. Which regions are leading in sales and adoption?

6. Who are the top companies competing in this market?

7. What emerging opportunities could shape the market’s future outlook?

8. How are technological advancements influencing product performance?

9. What regulatory trends affect product development and market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation